Arbor, Vol 194, No 789 (2018)

Terapias avanzadas en enfermedades raras


https://doi.org/10.3989/arbor.2018.789n3009

Cristina Fillat
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), España
orcid http://orcid.org/0000-0002-0801-3338

Marcela del Río
Universidad Carlos III de Madrid - Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) - Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (IIS-FJD), España
orcid http://orcid.org/0000-0003-2910-7189

Lucía Martínez-Santamaría
Universidad Carlos III de Madrid - Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) - Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (IIS-FJD), España
orcid http://orcid.org/0000-0002-9637-2364

Juan A. Bueren
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) - Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (IIS-FJD), España
orcid http://orcid.org/0000-0002-3228-7013

Resumen


Las terapias avanzadas comprenden un grupo de medicamentos biológicos basados en la terapia génica, la terapia celular y la ingeniería de tejidos. En este artículo se presentan algunos conceptos básicos, se describen las estrategias más prometedoras y se detallan los resultados de diferentes ensayos clínicos para un grupo significativo de enfermedades, especialmente las enfermedades hereditarias monogénicas. Se hace un mayor hincapié en la terapia génica ex vivo en enfermedades del sistema hematopoyético, al ser el grupo de enfermedades pioneras que además han orientado la investigación en el campo. Destacamos también algunos ejemplos de éxito de terapia génica in vivo y señalamos la contribución de la terapia celular y de la ingeniería de tejidos al grupo de enfermedades raras de la piel. Pretendemos con ello dar una visión de la situación de las terapias avanzadas en enfermedades raras y señalamos algunas de las vías de futuro orientadas al desarrollo de tratamientos más eficaces y seguros.

Palabras clave


Terapia génica; terapia celular; ingeniería de tejidos; enfermedades raras

Texto completo:


HTML PDF XML

Referencias


Adair, J. E., Sevilla, J., Díaz de Heredia, C., Becker, P. S., Kiem, H-P. y Bueren, J. A. (2016). Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia. Current Gene Therapy, 16 (5), pp. 338-348.

Aiuti, A., Biasco, L., Scaramuzza, S., Ferrua, F., Cicalese, M. P., Baricordi […] y Naldini, L. (2013). Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science, 341 (6148), 1233151.

Aiuti, A. y Roncarolo, M. G. (2009). Ten years of gene therapy for primary immune deficiencies. Hematology. American Society of Hematology Education Program Book, 2009 (1), pp. 682-689.

Aiuti, A., Roncarolo, M. G. y Naldini, L. (2017). Gene therapy for ADA?SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products. EMBO Molecular Medicine, 9 (6), e201707573.

Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A. […] y Bordignon, C. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science, 296 (5577), pp. 2410-2413.

Atala, A. (2007) Engineering tissues, organs and cells. Journal of Tissue Engineering and Regenerative. Medicine, 1(2), pp. 83-96.

Bainbridge, J. W., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K. […] y Ali, R. R. (2008). Effect of gene therapy on visual function in Leber’s congenital amaurosis. The New England Journal of Medicine, 358 (21), pp. 2231-2239.

Bajaj, P., Schweller, R. M., Khademhosseini, A., West, J. L. y Bashir, R. (2014). 3D biofabrication strategies for tissue engineering and regenerative medicine. Annual Review of Biomedical Engineering, 16, pp. 247-276.

Bauer, J. W., Koller, J., Murauer, E. M., Rosa, L. de, Enzo, E., Carulli, S. […] y Luca, M. de (2017). Closure of a large chronic wound through transplantation of gene-corrected epidermal stem cells. The Journal of Investigative Dermatology 137 (3), pp. 778-781.

Bennett, J., Ashtari, M., Wellman, J., Marshall, K. A., Cyckowski, L. L., Chung, D. C. […] y Maguire, A. M. (2012). AAV2 gene therapy readministration in three adults with congenital blindness. Science Translational Medicine, 4 (120), 120ra15.

Biffi, A., Montini, E., Lorioli, L., Cesani, M., Fumagalli, F., Plati, T. […] y Naldini, L. (2013). Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science, 341 (6148), 1233158.

Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., Shearer, G. […] y Anderson, W. F. (1995). T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science, 270 (5235), pp. 475-480.

Bordignon, C., Mavilio, F., Ferrari, G., Servida, P., Ugazio, A. G., Notarangelo, L. D. […] y Gillio, A. P. (1993). Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID. Human Gene Therapy, 4 (4), pp. 513-520.

Boztug, K., Schmidt, M., Schwarzer, A., Banerjee, P. P., Díez, I. A., Dewey, R. A. […] y Klein, C. (2010). Stem-cell gene therapy for the Wiskott-Aldrich syndrome. The New England Journal of Medicine, 363 (20), pp. 1918- 1927.

Braun, C. J., Boztug, K., Paruzynski, A., Witzel, M., Schwarzer, A., Rothe, M. […] y Klein, C. (2014). Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Science Transational. Medicine, 6 (227), 227ra33.

Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I. […] y Aubourg, P. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science, 326 (5954), pp. 818-823.

Carulli, S., Contin, R., Rosa, L. de, Pellegrini, G., Luca, M. de (2013). The long and winding road that leads to a cure for epidermolysis bullosa. Regenerative Medicine, 8 (4), pp. 467-481.

Cavazzana-Calvo, M., Hacein-Bey, S., Saint Basile, G. de, Gross, F., Yvon, E., Nusbaum, P. […] y Fischer, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288 (5466), pp. 669- 672.

Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F. […] y Leboulch, P. (2010). Transfusion independence and HMGA2 activation after gene therapy of human ?-thalassaemia. Nature, 467 (7313), pp. 318-322.

Conget, P., Rodríguez, F., Kramer, S., Allers, C., Simon, V., Palisson, F. […] y Yubero, M. J. (2010). Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy, 12 (3), 429-431.

Di, W. L., Larcher, F., Semenova, E., Talbot, G. E., Harper, J. I., Río, M. del […] y Qasim, W. (2011). Ex-vivo gene therapy restores LEKTI activity and corrects the architecture of Netherton syndrome-derived skin grafts. Molecular Therapy, 19 (2), pp. 408-416.

Ehrenreich, M. y Ruszczak, Z. (2006). Update on tissue-engineered biological dressings. Tissue Engineering, 12 (9), pp. 2407-2424.

El-Darouti, M., Fawzy, M., Amin, I., Abdel Hay, R., Hegazy, R., Gabr, H. y El-Maadawi, Z. (2016). Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: a randomized controlled trial. Dermatologic Therapy, 29 (2), pp. 96-100.

Escámez, M. J., Martínez-Santamaría, L., García, M., Guerrero-Aspizua, S., Carretero, M., Larcher, F., Meana, A., Río, M. del (2011). Bioengineered Skin. En Khopkar, U. (ed.). Skin Biopsy. Perspectives. InTech, pp. 261-296.

Fillat, C. y Altafaj, X. (2012). Gene Therapy for Down Syndrome. Progress in Brain Research, 197, pp. 237-247.

Gache, Y., Baldeschi, C., Río, M. del, Gagnoux-Palacios, L., Larcher, F., Lacour, J. P. y Meneguzzi, G. (2004). Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa. Human Gene Therapy, 15 (10), pp. 921-933.

García-Gómez, M., Calabria, A., García- Bravo, M., Benedicenti, F., Kosinski, P., López-Manzaneda, S. […] y Segovia, J. C. (2016). Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency. Molecular Therapy, 24 (7), pp. 1187-1198.

Gaspar, H. B., Parsley, K. L., Howe, S., King, D., Gilmour, K. C., Sinclair, J. […] y Thrasher, A. J. (2004). Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. The Lancet, 364 (9452), pp. 2181-2187.

Georgiadis, C., Syed, F., Petrova, A., Abdul-Wahab, A., Lwin, S. M., Farzaneh, F. […] y Qasim, W. (2016). Lentiviral engineered fibroblasts expressing codon-optimized COL7A1 restore anchoring fibrils in RDEB. Journal of Investigative Dermatology, 136 (1), pp. 284-292.

González-Murillo, A., Lozano, M. L., Álvarez, L., Jacome, A., Almarza, E., Navarro, S. […] y Río, P. (2010). Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia. Human Gene Therapy, 21(5), pp. 623-630.

Guo, Z., Higgins, C. A., Gillette, B. M., Itoh, M., Umegaki, N., Gledhill, K. […] y Christiano, A. M. (2013). Building a microphysiological skin model from induced pluripotent stem cells. Stem Cell Research Therapy, 4 (1), S2.

Hacein-Bey-Abina, S., Deist, F. Le, Carlier, F., Bouneaud, C., Hue, C., Villartay, J. P. de […] y Cavazzana-Calvo, M. (2002). Sustained correction of X-Linked severe combined immunodeficiency by ex vivo gene therapy. The New England Journal of Medicine, 346 (16), pp. 1185-1193.

Hacein-Bey-Abina, S., Pai, S. Y., Gaspar, H. B., Armant, M., Berry, C. C., Blanche, S. […] y Thrasher, A. J. (2014). A modified ?-retrovirus vector for X-linked severe combined immunodeficiency. The New England Journal of Medicine, 371 (15), pp. 1407-1417.

Hacein-Bey-Abina, S., Saint Basile, G. de y Cavazzana-Calvo, M. (2003). Gene therapy of X-linked severe combined immunodeficiency. Methods in Molecular Biology, 215, pp. 247-259.

Haurigot, V., Marcó, S., Ribera, A., García, M., Ruzo, A., Villacampa, P. […] y Bosch, F. (2013). Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy. The Journal of Clinical Investigation, 123 (8), pp. 3254-3271.

Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L. […] y Jacobson, S. G. (2008). Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Human Gene Therapy, 19 (10), pp. 979-990.

Hickerson, R. P., Smith, F. J., Reeves, R. E., Contag, C. H., Leake, D., Leachman, S. A. […] y Kaspar, R. L. (2008). Single-nucleotide-specific siARN targeting in a dominant-negative skin model. Journal of Investigative Dermatology, 128 (3), pp. 594-605.

Hovnanian, A., Bodemer, C. y McGrath, J. A. (2014). Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector (GENEGRAFT). Human Gene Therapy Clinical Development, 25 (2), pp. 65–66.

Kelly, P. F., Radtke, S., Kalle, C. von, Balcik, B., Bohn, K., Mueller, R. […] y Williams, D. A. (2007). Stem cell collection and gene transfer in Fanconi anemia. Molecular Therapy, 15 (1), pp. 211-219.

Kohn, D. B., Hershfield, M. S., Carbonaro, D., Shigeoka, A., Brooks, J., Smogorzewska, E. M. […] y Parkman, R. (1998). T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nature Medicine, 4 (7), pp. 775-780.

Leachman, S. A., Hickerson, R. P., Schwartz, M. E., Bullough, E. E., Hutcherson, S. L., Boucher, K. M. […] y Kaspar, R. L. (2010). First-in-human mutation-targeted siARN phase Ib trial of an inherited skin disorder. Molecular Therapy, 18 (2), pp. 442-446.

Lee, V., Singh, G., Trasatti, J. P., Bjornsson, C., Xu, X., Tran, T. N. […] y Karande, P. (2014). Design and fabrication of human skin by three-dimensional bioprinting. Tissue Engineering. Part C: Methods, 20 (6), pp. 473- 484.

León-Rico, D., Aldea, M., Sánchez-Baltasar, R., Mesa-Núñez, C., Record, J., Burns, S. O. […] y Almarza, A. (2016). Lentiviral vector mediated correction of a mouse model of Leukocyte Adhesion Deficiency Type I. Human Gene Therapy, 27 (9), pp. 668-678.

Lombardo, A. y Naldini, L. (2014). Genome Editing: A tool for research and therapy: Targeted genome editing hits the clinic. Nature Medicine, 20 (10), pp. 1101-1103.

Llames, S., García, E., García, V., Río, M. del, Larcher, F., Jorcano, J. L. [...] y Meana, A. (2006). Clinical results of an autologous engineered skin. Cell and Tissue Banking, 7 (1), pp. 47-53.

Llames, S. G., Río, M. del, Larcher, F., García, E., García, M., Escámez, M. J. […] y Meana, A. (2004). Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Transplantation, 77 (3), pp. 350-355.

Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh Jr., E. N, Mingozzi, F., Bennicelli, J. […] y Bennett, J. (2008). Safety and efficacy of gene transfer for Leber’s congenital amaurosis. The New England Journal Medicine, 358 (21), pp. 2240-2248.

Mavilio, F., Pellegrini, G., Ferrari, S., Nunzio, F. di, Iorio, E. di, Recchia, A. […] y Luca, M. de (2006). Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nature Medicine, 12 (12), pp. 1397-1402.

Meza, N. W., Alonso-Ferrero, M. E., Navarro, S., Quintana-Bustamante, O., Valeri, A., García-Gómez, M. […] y Segovia, J. C. (2009). Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme. Molecular Therapy, 17 (12), pp. 2000-2009.

Mingozzi, F. y High, K. A. (2011). Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nature Reviews Genetics, 12 (5), pp. 341-355.

Modlich, U., Navarro, S., Zychlinski, D., Maetzig, T., Knoess, S., Brugman, M. H. […] y Baum, C. (2009). Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Molecular Therapy, 17 (11), pp. 1919-1928.

Ott, M. G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U. […] y Grez, M. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nature Medicine, 12 (4), pp. 401-409.

Petrof, G., Lwin, S. M., Martínez-Queipo, M., Abdul-Wahab, A., Tso, S., Mellerio, J. E. […] y McGrath, J. A. (2015). Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa. The Journal of Investigative Dermatology, 135 (9), pp. 2319-2321.

Petrof, G., Martínez-Queipo, M., Mellerio, J. E., Kemp, P. y McGrath, J. A. (2013). Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial. British Journal of Dermatology, 169 (5), pp. 1025-1033.

Río, M. del, Larcher, F., Serrano, F., Meana, A., Muñoz, M., García, M. [...] y Jorcano, J. L. (2002). A preclinical model for the analysis of genetically modified human skin in vivo. Human Gene Therapy, 13 (8), pp. 959-968.

Río, P., Navarro, S., Guenechea, G., Sánchez-Domínguez, R., Lamana, M. L., Yañez, R. […] y Bueren, J. (2017). Engraftment and in vivo proliferation advantage of gene corrected mobilized CD34+ cells from Fanconi anemia patients. Blood, 130 (13).

Rosa, L. de, Carulli, S., Cocchiarella, F., Quaglino, D., Enzo, E., Franchini, E. […] y Luca, M. de (2013). Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. Stem Cell Reports, 2 (1), pp. 1-8.

Salido, E., Rodríguez-Pena, M., Santana, A., Beattie, S. G., Petry, H. y Torres, A. (2011). Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transfer. Molecular Therapy, 19 (5), pp. 870-875.

Schröder, A. R., Shinn, P., Chen, H., Berry, C., Ecker, J. R. y Bushman, F. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110 (4), pp. 521-529.

Siprashvili, Z., Nguyen, N. T., Gorell, E. S., Loutit, K., Khuu, P., Furukawa, L. K. […] y Marinkovich, M. P. (2016). Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA, 316 (17), pp. 1808-1817.

Song, J. J. y Ott, H. C. (2011). Organ engineering based on decellularized matrix scaffolds. Trends in Molecular Medicine, 17 (8), pp. 424-432.

Stein, S., Ott, M. G., Schultze-Strasser, S., Jauch, A., Burwinkel, B., Kinner, A. […] y Grez, M. (2010). Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nature Medicine, 16 (2), pp. 198- 204.

Tamai, K., Yamazaki, T., Chino, T., Ishii, M., Otsuru, S., Kikuchi, Y. […] y Kaneda, Y. (2011). PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proceedings of the National Academy of Sciences USA, 108 (16), pp. 6609- 6614.

Tolar, J., Becker, P. S., Clapp, D. W., Hanenberg, H., Heredia, C. D. de, Kiem, H. P. […] y Bueren, J. (2012). Gene therapy for Fanconi anemia: one step closer to the clinic. Human Gene Therapy, 23 (2), pp. 141-144.

Tolar, J. y Wagner, J. E. (2013). Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix. The Lancet, 382 (9899), pp. 1214-1223.

Torres-Torronteras, J., Viscomi, C., Cabrera-Pérez, R., Cámara, Y., Meo, I. di, Barquinero, J. [...] y Martí, R. (2014). Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE. Molecular Therapy, 22 (5), pp. 901-907.

Venugopal, S. S., Yan, W., Frew, J. W., Cohn, H. I., Rhodes, L. M., Tran, K. […] y Murrell, D. F. (2013). A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. Journal of American Academy of Dermatology, 69 (6), pp. 898-908.

Wagner, J. E., Ishida-Yamamoto, A., McGrath, J. A., Hordinsky, M., Keene, D. R., Woodley, D. T. […] y Tolar, J. (2010). Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. The New England Journal of Medicine, 363 (7), pp. 629-639.

Wong, T., McGrath, J. A. y Navsaria, H. (2007). The role of fibroblasts in tissue engineering and regeneration. British Journal of Dermatology, 156 (6), pp. 1149-1155.




Copyright (c) 2018 Consejo Superior de Investigaciones Científicas (CSIC)

Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento 4.0 Internacional.


Contacte con la revista arbor@csic.es

Soporte técnico soporte.tecnico.revistas@csic.es